What is the main business of Centrala Farmaceutyczna Cefarm?

The main business activity of Centrala Farmaceutyczna Cefarm focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 13, 2003.

Where is the headquarters located?

The headquarters is located at: Jana Kazimierza 16, 01-248 Warszawa.

Who is on the management board?

The management board consists of: Grzegorz Ornowski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 55,400,000 (approx. $15 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What revenue was generated?

In 2023, the company generated total revenue of $349,390,561, representing an increase of 14.4% compared to 2022.

Yes, in 2023 the company was profitable, achieving a net profit of $2,541,409, meaning the company increased its profit by 105.4%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $329,614,320 in 2023, representing 95% of all operating expenses.

Centrala Farmaceutyczna CefarmS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2003-03-13

Share capital

55 400 000,00 PLN

Activity description

Centrala Farmaceutyczna Cefarm is a pharmaceutical distribution company that offers over 14,000 product items, including medicinal products, dietary supplements, and medical devices. It provides logistics services related to transportation and specialized warehouse rentals, and operates a manufacturing facility for medicinal products. The company also specializes in emergency medication delivery and supports clinical research services.

Registered address

Jana Kazimierza 16, 01-248 Warszawa, Poland

Website

cefarm.com.pl

Phone

Electronic delivery address

AE:PL-71356-32906-UDWBW-27

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 457.05mMedianUSD 873.84kAverageUSD 20.03m

Net profit

This companyUSD 1.42mMedianUSD 28.21kAverageUSD 815.54k

Operating costs

This companyUSD 453.21mMedianUSD 801.08kAverageUSD 18.78m

Assets

This companyUSD 164.60mMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 1996-01-01. Active

PKO Bank Polski
69 1020 1026 0000 1402 0407 1650
Bank Millennium
65 1160 2202 0000 0002 2974 4328

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

1894 tenders recorded as contractor: 339 national ($15,711,327) and 1555 EU ($5,074,439,467).

Publication date	Subject	Amount	Contracting authority
Oct 2, 2026	Zakup i sukcesywna dostawa leków onkologicznych oraz leków różnych.	——	Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie
Oct 2, 2026	Dostawa leków cz. III	——	Samodzielny Publiczny Wojewódzki Szpital Chirurgii Urazowej Im.Dr.Janusza Daaba w Piekarach Śląskich
Oct 2, 2026	Zakup i sukcesywna dostawa leków onkologicznych oraz leków różnych.	——	Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Lidia Kardacz Matuszkiewicz — Attorney-in-fact (joint)

Danuta Józefa Kopias — Attorney-in-fact (joint)

Grzegorz Ornowski — President of the Management Board

Manner of representation

Joint action of two members of the management board, or one member of the management board jointly with a commercial proxy. If the management board is a one-person management board, one member of the management board is authorised to make declarations.

Supervisory board

Anna Kucharska — Supervisory Board Member

Hubert Dominik Zacharski — Supervisory Board Member

Mariusz Domurad — Supervisory Board Member

Julia Joanna Zdanukiewicz — Supervisory Board Member

Rafał Maciej Król — Supervisory Board Member

Ownership

Owner
Skarb Państwa

Beneficial owners

Person	Rights
Grzegorz Ornowski (60)	Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

Name	Revenue	Website
BASF Polskasp. z o.o.	$742,117,528.88	basf.pl
Bayersp. z o.o.	$624,313,880.67	bayer.pl
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.	$600,815,720.02	slawex.com.pl
HurtapS.A.	$480,276,955.20	hurtap.com.pl
Sanofisp. z o.o.	$384,123,246.36	sanofi.pl
Przedsiębiorstwo Handlowo-Promocyjne Agro-Efektsp. z o.o.	$313,751,811.50	agroefekt.pl
NovoS.A.	$209,522,261.96	novo-sa.pl
Bialmedsp. z o.o.	$203,238,055.12	bialmed.pl
FoodcomS.A.	$136,969,474.32	foodcom.pl
LubfarmS.A.	$123,208,945.21	lubfarm.pl

Change history

Date	Event
2015-07-06	PKD change (Removed: 02.40.Z, 10.39.Z, 46.18.Z, 46.19.Z, 46.21.Z, 46.22.Z, 46.31.Z, 46.33.Z, 46.42.Z, 46.75.Z, 46.76.Z, 46.90.Z, 47.21.Z, 47.29.Z, 47.51.Z, 47.52.Z, 47.53.Z, 47.75.Z, 47.76.Z, 47.78.Z, 49.42.Z, 52.10.A, 55.20.Z, 70.21.Z, 70.22.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.90.Z, 82.20.Z, 85.60.Z, 86.90.E; Added: 52.24.C, 82.92.Z)
2010-02-26	PKD change (Added: 46.18.Z, 46.19.Z)
2009-10-01	PKD change (Added: 55.20.Z)
2008-09-22	PKD change (Removed: 51.21.Z, 51.22.Z, 51.31.Z, 51.33.Z, 51.42.Z, 51.45.Z, 51.46.Z, 51.55.Z, 51.56.Z, 51.90.Z, 52.27.B, 52.31.Z, 52.32.Z, 52.33.Z, 52.41.Z, 52.46.Z, 52.48.B, 52.48.F, 52.48.G, 60.24.A, 60.24.B, 63.12.C, 63.40.C, 70.20.Z, 74.13.Z, 74.14.A, 74.40.Z, 85.14.F; Added: 02.40.Z, 10.39.Z, 46.21.Z, 46.22.Z, 46.31.Z, 46.33.Z, 46.42.Z, 46.45.Z, 46.46.Z, 46.75.Z, 46.76.Z, 46.90.Z, 47.21.Z, 47.29.Z, 47.51.Z, 47.52.Z, 47.53.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.76.Z, 47.78.Z, 49.41.Z, 49.42.Z, 52.10.A, 52.10.B, 52.29.C, 68.20.Z, 70.21.Z, 70.22.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.90.Z, 82.20.Z, 85.60.Z, 86.90.E)
2005-01-31	PKD change (Removed: 51.70.A, 52.42.Z, 74.14; Added: 51.90.Z, 52.41.Z, 70.20.Z, 74.14.A, 85.14.F)

FAQ

Last updated: 2026-07-09